Bonus episode: Meet GOLD’s latest catalyst – Roche’s Dr Peter Ahnesorg

"}}},"VERSION":"9.14.7"}"> Tune in for a sneak peek of GOLD's latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.   In this exclusive teaser of the full interview, Peter talks about why he left research for industry, Roche's commitment to ensuring equitable access to its medicines and what he believes are the qualities of a good leader today.   ost/podcast-changing-the-tide-on-health-inequities","target":"_blank","rel":""}},"1":{"type":"LINK","mutability":"MUTABLE","data":{"url":"https://www.emg-gold.com/post/podcast-do-happy-employees-equal-better-innovation","target":"_blank","rel":""}},"2":{"type":"LINK","mutability":"MUTABLE","data":{"url":"https://www.emg-gold.com/post/podcast-a-high-speed-chase-for-oncology-innovation","target":"_blank","rel":""}}},"VERSION":"9.14.7"}"> If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Podcast: Changing the tide on health inequities
• Podcast: Do happy employees equal better innovation?
• Last week’s podcast: A high-speed chase for oncology innovation